How is the Pediatric Drugs Market Poised for Growth: Trends and Opportunities Through 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the pediatric drugs market?
The market size of pediatric drugs has seen swift growth in the recent past. It is predicted to expand from $157.0 billion in 2024 to $181.02 billion in 2025, with a compound annual growth rate (CAGR) of 15.3%. The surge in the historic phase can be ascribed to the increasing need for corresponding medications, high demand from the escalating pediatric population, improved awareness about pediatric diseases, the growth in pediatric oncology, the rise in digital health and telemedicine, and heightened cooperation in the development of pediatric drugs.
What will be the pediatric drugs market size in the future?
The pediatric medications market is anticipated to expand rapidly over the coming years, with a projected worth of $316.0 billion in 2029, marking a Compound Annual Growth Rate (CAGR) of 14.9%. The forecast period’s growth is due to increased child population, a surge in pediatric mental health disorders, a rise in chronic conditions among children, accelerated children vaccination rates, and an augmented demand for pediatric mental health drugs. Looking forward, key trends for the forecast period will likely involve individualized medicine for children, the implementation of technology in pediatric drug administration, the adoption of telemedicine and digital health solutions, the improvement of pediatric clinical trials, and cooperation between pediatricians and pharmacists.
Get your pediatric drugs market report here!
https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report
What main drivers are fueling expansion in the pediatric drugs market?
Acceleration in the number of preterm births, where babies are born prior to 37 weeks of gestation instead of the average 40 weeks, is projected to fuel the expansion of the pediatric drugs market. Factors contributing to this surge in preterm births include increased age of mothers, lifestyle decisions, medical conditions, multiple pregnancies, and lack of appropriate prenatal care. Pediatric drugs play a crucial role in promoting the health and growth of premature infants by providing specialized treatments for issues such as respiratory difficulties, infections, and nutritional deficiencies. For example, Tommy’s, a charity organization based in the UK, published a report in December 2022 stating that the percentage of live premature births in England and Wales had risen to 7.9% in 2022 from 7.5% in 2021, accounting for more than 53,000 preterm babies born in 2022. Thus, the increasing prevalence of preterm births is propelling the pediatric drugs market’s growth.
What key areas define the segmentation of the global pediatric drugs market?
The pediatric drugs market covered in this report is segmented –
1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs
2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids
2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)
3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives
4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp
Who are the dominant players expanding their reach in the pediatric drugs market?
Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila
What emerging trends are influencing the growth of the pediatric drugs market?
Major players in the pediatric drugs market are investing in creating groundbreaking drugs like wholly human monoclonal antibodies, with the aim of enhancing treatment results and reducing side effects for pediatric patients. Wholly human monoclonal antibodies are antibodies completely derived from human genetic sequences, thereby reducing the likelihood of immune system reactions, in contrast to chimeric or humanized monoclonal antibodies. These antibodies are manufactured using state-of-the-art biotechnology methods like transgenic mice embedded with human antibody genes or phage display technology. As an example, in August 2022, Johnson and Johnson, a pharmaceutical company based in the US, obtained FDA endorsement for STELARA (ustekinumab) for treating pediatric patients six years and older with active psoriatic arthritis (PsA). This endorsement marks considerable progress, as STELARA is the sole biologic treatment targeting interleukin-12 (IL-12) and interleukin-23 (IL-23), essential cytokines taking part in inflammatory responses related to autoimmune ailments. Active PsA is a rare disorder impacting about 5-8% of children suffering from chronic inflammatory arthritis, causing symptoms like joint swelling and skin lesions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249
Which regions are emerging as leaders in the pediatric drugs market?
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Water-Soluble Vitamin And Mineral Feed Supplements Global Market Report 2025
Gummy Vitamins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gummy-vitamins-global-market-report
Cell and Gene Therapy Global Market Report 2025
https://thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
